logo

For the Inventor, By the Inventor

Ann Arbor, MI, United States of America

Paul C Unangst

This inventor holds 52 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Compounds (CPC class 5482). Top assignees: Warner-Lambert Company, Millennium Pharmaceuticals Limited, Other. Active years: 1977-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul C Unangst. Retrieved from https://idiyas.com/inventor/paul-c-unangst

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 52

% Patents Active = 90.4


Average Co-Inventor Count = 3.9

ph-index = 11

Forward Citations = 437(Granted Patents)

Forward Citations (Not Self Cited) = 422(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Hackettstown, NJ (US) (1977 - 1979)
  • Ann Arbor, MI (US) (1980 - 2007)

Company Filing History:

goldMedal49 out of 2,538 
 
Warner-Lambert Company
 patents
silverMedal2 out of 854 
 
Millennium Pharmaceuticals Limited
 patents
bronzeMedal1 out of 834,513 
Other
 patents

Years Active: 1977-2007

Loading Chart...
Loading Chart...
Areas of Expertise:
PPAR Modulators
MCP-1 Antagonists
Psychosis Treatment
Inflammatory Disease
Antipsychotic Methods
Aryl Alkenamides
Benzothiophenes
Enolamides
Cell Adhesion Inhibitors
Anti-Inflammatory
Amino Acid Analogs
Chemokine Receptors
52 patents (USPTO):Explore Patents
1. RE39916 - Compounds that modulate PPAR activity and methods for their preparation (2007-11-05),
2. 7244763 - Compounds that modulate PPAR activity and methods of preparation (2007-07-17),
3. 7067538 - MCP-1 receptor antagonists and methods of use thereof (2006-06-27),
4. 6964983 - Compounds that modulate PPAR activity and methods for their preparation (2005-11-15),
5. 6939875 - Compounds that modulate PPAR activity and methods for their preparation (2005-09-06),
6. 6875780 - Compounds that modulate PPAR activity and methods for their preparation (2005-04-05),
7. 6458806 - Aryl alkenamides derivatives as MCP-1 antagonists (2002-10-01),
8. 6316449 - Chemokine receptor antagonists (2001-11-13),
9. 6051605 - Method of treating psychosis and schizophrenia (2000-04-18),
10. 6020364 - Compounds and method of treating psychosis and schizophrenia (2000-02-01),
11. 5916914 - Compounds and method of treating psychosis and schizophrenia (1999-06-29),
12. 5760050 - Antipsychotic method utilizing certain (1998-06-02),
13. 5565446 - Benzothiophene, benzofuran and indole-thiazepinones, oxazepinones and (1996-10-15),
14. 5494927 - 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of (1996-02-27),
15. 5489586 - Method for treating inflammatory disease in humans (1996-02-06),

Title: The Innovative Mind of Paul C Unangst

Introduction: Paul C Unangst is a distinguished inventor based in Ann Arbor, MI (US) known for his groundbreaking contributions to various fields through his inventive spirit and dedication to innovation.

Latest Patents: Paul C Unangst's latest patents showcase his expertise in developing cutting-edge technologies that have the potential to revolutionize industries and improve everyday life for people around the world.

Career Highlights: Throughout his illustrious career, Paul C Unangst has consistently demonstrated a knack for identifying gaps in the market and creating innovative solutions to address them. His passion for pushing the boundaries of what is possible has led to the successful development of numerous patented inventions.

Collaborations: Paul C Unangst has collaborated with leading research institutions, universities, and companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion: In conclusion, Paul C Unangst's relentless pursuit of innovation and his remarkable creativity have established him as a prominent figure in the world of inventors. His contributions continue to inspire and shape the future of technology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…